Onyx Biotec Limited — Results, 22-04-2026: Reply to Clarification- Financial results

Onyx Biotec clarified its IPO fund utilization by submitting the required auditor-signed certificate. Auditors confirmed that the ₹25.38 Cr IPO proceeds were mostly used as planned. A minor increase in net proceeds, from lower actual expenses, slightly raised the general corporate purposes allocation.